Ravi Salgia, MD, PhD, is the Arthur and Rosalie Kaplan Chair in Medical Oncology and the Associate Director for Clinical Sciences Research in the City of Hope Comprehensive Cancer Center in Duarte, California.
Prior to joining City of Hope, Dr. Salgia served as tenured professor of Medicine, Pathology, and Dermatology; Director of the Thoracic Oncology Program and Aerodigestive Tract Program Translational Research Lab, Section of Hematology/Oncology; Vice Chair for Translational Research, Department of Medicine; and Associate Director for Translational Science at the University of Chicago Comprehensive Cancer Center in Chicago, Illinois.
Dr. Salgia earned his undergraduate degree summa cum laude in mathematics, biology, and chemistry, and then his MD, and PhD, from Loyola University in Chicago, Illinois, where he also completed fellowships in neurochemistry and physiology. He continued his postgraduate training with an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore, Maryland, followed by a fellowship in medical oncology at Dana-Farber Cancer Institute in Boston, Massachusetts, during which time he also served as a clinical fellow at Harvard Medical School in Boston.
Dr. Salgia is frequently invited to present his work at national and international conferences and symposia and is the recipient of several honors and awards. He is serving as a chartered member of NIH/NCI’s Tumor Progression and Metastasis Study Section, and he was also elected as the Translational Science Representative on NCI's Thoracic Malignancy Steering Committee.
Board-certified in internal medicine and medical oncology, Dr. Salgia is the current chief editor for Cancer Commons, and the co-chief editor for the Journal of Carcinogenesis. He also serves on the editorial advisory boards of four additional journals. Dr. Salgia has authored 286 peer-reviewed articles, reviews and editorials, one book, and 34 book chapters.
